MedPath

Instrument-assisted Soft Tissue Mobilization Versus Integrated on Mechanical Neck Pain

Not Applicable
Completed
Conditions
Non-specific Chronic Mechanical Neck Pain
Interventions
Other: integrated neuromuscular inhibition technique
Other: instrument assisted soft tissue mobilization
Other: conventional therapy
Registration Number
NCT04702100
Lead Sponsor
Cairo University
Brief Summary

the aim of this study is to investigate the efficacy of instrumented assisted soft tissue mobilization versus integrated neuromuscular inhibition technique on mechanical non-specific neck pain

Detailed Description

Mechanical neck pain is a prevalent condition in various populations. Neck pain occurrence is affected by several factors, involving environmental, psychological, and social aspects. Neck pain represents the fourth major disorder responsible for a person's year lived with disability and ranked eleventh as disability-adjusted life years of a person. The neck pain incidence ranges from 10.4 to 23.3% in 1-year time, while the range of prevalence was 0.4 to 86.8%. It has a high prevalence among computer users, office workers, and females, especially females aged 35 to 49 years old. Myofascial trigger point (MTrP) might play an important role in the formation of mechanical neck pain and is known as a hyperirritable spot in skeletal muscle that is accompanied with a hypersensitive palpable nodule in a taut band. IASTM and integrated play an important role in the treatment of mechanical neck pain.this trial has three groups; one will receive IASTM+ conventional, the second will receive integrated + conventional and the third will receive conventional treatment for four week

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  1. diagnosed as non-specific neck pain with upper trapezius active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern
  2. body mass index from 18 to 25 kg/m2
  3. their ages from 18-35
Exclusion Criteria
  1. if they had trigger point injections within the past 6 months
  2. history of neck or upper back surgery, trauma or fracture
  3. history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities
  4. cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
integrated neuromuscular inhibition techniqueintegrated neuromuscular inhibition techniquethe patients will receive integrated neuromuscular inhibition technique+ conventional therapy. three times a week for four week
instrument assisted soft tissue mobilizationinstrument assisted soft tissue mobilizationthe patients will receive instrument-assisted soft tissue mobilization+conventional therapy three times per week for four week
integrated neuromuscular inhibition techniqueconventional therapythe patients will receive integrated neuromuscular inhibition technique+ conventional therapy. three times a week for four week
conventional therapyconventional therapythe patients will receive conventional therapy three times a week for four week
instrument assisted soft tissue mobilizationconventional therapythe patients will receive instrument-assisted soft tissue mobilization+conventional therapy three times per week for four week
Primary Outcome Measures
NameTimeMethod
pain intensityup to four weeks

The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

Secondary Outcome Measures
NameTimeMethod
neck disabilityup to four weeks

will be measured by Arabic neck disability index

muscle amplitude in the form of normalized root mean square (RMS)up to four weeks

muscle amplitude will be measured by surface electromyography for upper trapezius

muscle fatigue in the form of median frequencyup to four weeks

muscle fatigue will be measured by surface electromyography for upper trapezius

Trial Locations

Locations (1)

Al Shaymaa Shaaban Abd El Azeim

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath